Mei Ri Jing Ji Xin Wen·2026-01-13 05:11Group 1 - A-shares experienced a collective decline, with sectors such as medical services, CRO concepts, and pharmaceutical commerce leading the gains, while commercial aerospace and large aircraft sectors faced losses [1] - The software industry plays a crucial role in the AI industry chain, providing core technical support and application implementation, with a focus on AI frameworks, development platforms, and algorithm models [1] - Anthropic launched its new model Claude Opus 4.5 for the healthcare sector, aiming to reduce labor costs and improve processing efficiency by covering high-frequency processes like pre-authorization and claims appeals [1] Group 2 - AI applications in healthcare are entering a rapid commercialization phase, significantly enhancing drug discovery efficiency, reducing candidate drug discovery time from 4.5 years to 12-18 months [2] - Key areas of focus include AI pharmaceutical platforms with global service capabilities, traditional CRO companies that support AI pharmaceutical validation, and preclinical and clinical CRO segments [2] - The application of AI is accelerating in medical imaging, in vitro diagnostics, and consumer health management sectors [2]